ACH-METHOTREXATE DIN 02509067
Status: Marketed
Holder: ACCORD HEALTHCARE INC
Molecule: METHOTREXATE (METHOTREXATE DISODIUM)
Available to quote
Health Canada record
| Active ingredient(s) | METHOTREXATE (METHOTREXATE DISODIUM) 2.5 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01BA01 METHOTREXATE |
| Original market date | 21-Oct-2021 |
| Current status date | 21-Oct-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Accord Healthcare Inc. — licence 101566, currently licensed, last inspection rating C (2024-11-26).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing METHOTREXATE (METHOTREXATE DISODIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02182963 | APO-METHOTREXATE | APOTEX INC | Tablet | METHOTREXATE (METHOTREXATE DISODIUM) 2.5 MG | Marketed |
| 02524023 | AURO-METHOTREXATE | AURO PHARMA INC | Tablet | METHOTREXATE (METHOTREXATE DISODIUM) 2.5 MG | Marketed |
| 02546515 | EUGIA-METHOTREXATE | EUGIA PHARMA INC. | Tablet | METHOTREXATE (METHOTREXATE DISODIUM) 2.5 MG | Approved |
| 02562979 | JAMP METHOTREXATE | JAMP PHARMA CORPORATION | Tablet | METHOTREXATE (METHOTREXATE DISODIUM) 2.5 MG | Approved |
| 02534916 | M-METHOTREXATE | MANTRA PHARMA INC | Tablet | METHOTREXATE (METHOTREXATE DISODIUM) 2.5 MG | Marketed |
| 02562839 | METHOTREXATE TABLETS, USP | PFIZER CANADA ULC | Tablet | METHOTREXATE (METHOTREXATE DISODIUM) 10 MG | Approved |
| 02170698 | PMS-METHOTREXATE | PHARMASCIENCE INC | Tablet | METHOTREXATE (METHOTREXATE DISODIUM) 2.5 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 24710 | 2020-12-01 | Abbreviated New Drug Submission (ANDS) |